Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
SION.OQ - Sionna Therapeutics Inc
Sionna Therapeutics Inc at TD Cowen Healthcare Conference
Mar 02, 2026 / 07:30PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you everyone for joining us here at the Siona Fireside chat at the TD Cowan Healthcare Conference. I'm covering analyst Rtu Bal, and with us today from Siona we have from my right, CEO Mike Cloonan, CFO Elena Ridlof, and CMO, Charlotte McKee.
Thank you guys for joining us today.
Soona leaders in NBD1.
Mechanistic medicines for CF, a new class that has really been, a focus of investor discussion in the CF field since you guys IPOed, but the original conversations always go back to, with generations of CF modulators, multiple generations of. CF modulators available. Each one with increased efficacy over the last, what's the rationale for pursuing NBD1 stabilizers as a next gen? What's

